GM CSF Human, His

Granulocyte Macrophage-Colony Stimulating Factor Human Recombinant, His Tag
Cat. No.
BT665
Source
Escherichia Coli.
Synonyms
CSF-2, MGI-1GM, GM-CSF, Pluripoietin-alpha, Molgramostin, Sargramostim, MGC131935, MGC138897.
Appearance
Sterile Filtered clear solution.
Purity
Greater than 95.0% as determined by:
(a) Analysis by RP-HPLC.
(b) Analysis by SDS-PAGE.
Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

GMCSF Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 127 amino acids fragment (18-144) and having a molecular mass of 18.98kDa with an amino-terminal hexahistidine tag.
GM-CSF Human Recombinant His is purified by proprietary chromatographic techniques.

Product Specs

Introduction
Granulocyte-macrophage colony-stimulating factor (GM-CSF) is a cytokine that regulates the production, differentiation, and function of granulocytes and macrophages. The active form of GM-CSF exists extracellularly as a homodimer. The gene encoding GM-CSF is located within a cluster of related genes on chromosome 5q31, a region associated with interstitial deletions in 5q- syndrome and acute myelogenous leukemia. This gene cluster also includes those encoding interleukins 4, 5, and 13. GM-CSF stimulates the growth and differentiation of hematopoietic precursor cells from various lineages, including granulocytes, macrophages, eosinophils, and erythrocytes. It is a potent species-specific growth factor produced by various cell types, such as T cells, B cells, macrophages, mast cells, and endothelial cells, in response to cytokine or immune stimulation.
Description
Recombinant Human GM-CSF, expressed in E. coli, is a single, non-glycosylated polypeptide chain encompassing amino acids 18-144. It contains an amino-terminal hexahistidine tag and has a molecular weight of 18.98 kDa. Purification is achieved using proprietary chromatographic techniques.
Physical Appearance
A clear, sterile-filtered solution.
Formulation
Granulocyte Macrophage Colony Stimulating Factor-His is supplied in a buffer containing 20mM Tris HCl (pH 8) and 50% glycerol.
Stability
For short-term storage (up to 4 weeks), store the solution at 4°C. For long-term storage, freeze the solution at -20°C. Avoid repeated freeze-thaw cycles.
Purity
The purity is determined to be greater than 95.0% using the following methods: (a) Reverse-phase high-performance liquid chromatography (RP-HPLC) (b) Sodium dodecyl-sulfate polyacrylamide gel electrophoresis (SDS-PAGE)
Synonyms
CSF-2, MGI-1GM, GM-CSF, Pluripoietin-alpha, Molgramostin, Sargramostim, MGC131935, MGC138897.
Source
Escherichia Coli.

Product Science Overview

Introduction

Granulocyte Macrophage-Colony Stimulating Factor (GM-CSF) is a cytokine that plays a crucial role in the stimulation of proliferation, differentiation, and survival of various hematopoietic cells, including mature neutrophils, macrophages, and dendritic cells . The recombinant form of GM-CSF, particularly the human recombinant version with a His tag, is widely used in research and therapeutic applications.

Structure and Function

GM-CSF is a glycoprotein composed of 127 amino acids. The human recombinant version is often tagged with a polyhistidine (His) tag to facilitate purification and detection. This His tag is a sequence of histidine residues that binds strongly to nickel ions, allowing for easy isolation of the protein using nickel-affinity chromatography.

GM-CSF is produced by various cell types, including fibroblasts, endothelial cells, and T lymphocytes, in response to microbial products or inflammatory cytokines . It is essential for the innate immune response, as it stimulates the proliferation and differentiation of granulocytes and macrophages, which are critical for fighting infections.

Preparation Methods

The production of recombinant human GM-CSF typically involves the expression of the protein in Escherichia coli (E. coli) cells. However, this process often results in the formation of inclusion bodies, which are aggregates of misfolded proteins . To obtain bioactive GM-CSF, these inclusion bodies must be solubilized, refolded, and purified. A simplified method for the efficient refolding and purification of recombinant human GM-CSF has been developed, which does not require extensive experience in protein refolding or purification .

Therapeutic Applications

Recombinant human GM-CSF is used as a biotherapeutic agent for immunocompromised individuals, such as those undergoing chemotherapy . It helps to reduce the duration and severity of neutropenia, a condition characterized by low levels of neutrophils, which can lead to severe infections. By stimulating the production of granulocytes and macrophages, GM-CSF enhances the body’s ability to fight infections and recover from chemotherapy-induced neutropenia.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.